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The white blood cell count is frequently used as a major 
tool in the differential diagnosis of infectious diseases. 
Although leukocytosis with a shift to the left is often indica¬ 
tive of bacterial infection, it is also known to accompany such 
stressful situations as diabetic ketoacidosis, burns, strenuous 
exercize, seizures, serum sickness, paroxysmal tachycardia, 
salicylate or hydrocarbon poisoning, ether anesthesia, the post- 
70 
operative state, immunizations, hemolysis, and serious hemorrhage. 
In his pioneer studies on the enzyme leukocyte alkaline phosphatase 
98 
(LAP), Wachstein discovered that the amount of LAP per neutrophil 
and the number of LAP(+)neutrophiIs increased with bacterial 
infection and he postulated that the increased enzyme activity 
in neutrophils under inflammatory stimuli probably signified 
92 
increased cell metabolism. Ruttenburg demonstrated increased 
LAP activity not only with bacterial infection, but also in 
pregnancy, leukemoid reactions, and some cases of myeloid 
10 
metaplasia and polycythemia vera. Beisel discovered that LAP 
rises witn some viral and rickettsial infections and that the 
rises in LAP with bacterial or viral infection are often variable 
in onset, sometime occurring several days after the fever and 
leukocytosis have disappeared. Thus, changes in LAP have 
proved to be of little value in the diagnosis of bacterial 
infection. 
A major step in the differentiation of bacterial infection 
from those non-bacterial illnesses often confused with bacterial 

infection because of fever, leukocytosis, and other clinical 
80 
symptoms has been made by Park and his associates with the use 
of the nitroblue tetrazolium (NBT) dye test. These investigators 
demonstrated that there is a significant difference in the per¬ 
centage of neutrophils reducing the dye to an intracellular blue- 
black formazan precipitate (NBT(+)neutrophils) in patients with 
active bacterial infection (mean 29-47%) vs. patients with viral 
illnesses or other noninfectious fevers (including tuberculosis 
and collagen diseases) and normal controls (mean 5.8-9.5%). 
Their results were confirmed in a larger series of patients by 
29,30 67,69 
Feigin et.al. in children and Matula and Paterson in adults 
- 41,48.49,50,77 
as well as in smaller series by other investigators. 
29,30 
In addition, Feigin's group, using discriminant analysis of the 
percentage and absolute number of NBT (+) cells, were able to 
construct a nomogram dividing their 349 febrile patients into 
4 groups: 1) normal subjects, 2) individuals with viral infection, 
noninfectious fevers, or partially treated bacterial infection, 
3) untreated bacterial infections and 4) bacterial infection un¬ 
responsive to the therapy provided. In my thesis, I have applied 
the NBT dye test to patients with cystic fibrosis in whom the 
detection of active bacterial infection is often difficult. My 
experimental proposals will be discussed later in the paper. 
NBT False Positive Results 
Despite significant support for the efficacy of the NBT 
test in the differential diagnosis of bacterial from non-bacterial 
2 

disease, there have been cases of false positive and false 
negative results. 
A number of false positive NBT results have been reported 
in the literature: 
A) Parasitic Diseases - NBT results in the range usually 
found in active bacterial infection (greater than 10% NBT (+) 
67,69 
neutrophils according to Matula and Paterson) have been found 
2,18,67,69,87 
in thirteen patients with malaria, in one patient each 
18 18 18 
with loiasis, trichinosis, and amebic liver absess and in three 
28 
dogs infected with Dirofilaria immitis (dog heartworm). 
B) Fungal Diseases - high NBT values have been reported 
80 
in four patients with Candida albicans septicemia and in two 
90 
patients with pulmonary nocardiosis. 
48 
C) Viral and Mycoplasma Infections - Humbert reported 
high NBT results in five out of twenty-five patients with viral 
central nervous system infections (all five suspected or proven 
26 
Echovirus infections) while Elgefors reported elevated NBT 
results in four out of eleven patients with viral meningitis - 
32 
one Coxsackie, two Herpes and one mumps meningitis. freeman 
recently demonstrated high NBT results in two patients with 
Mycoplasma pneumonia in which seroconversion was demonstrated. 
82,83 
D) Newborn and Premature Infants - Park et.al, 
4 9 9 9 — 
Humbert ejt. aM. , and Wehinger have demonstrated elevated NBT 
80 
responses in healthy term infants using the method of Park et.al. 
37 
(Park, Humbert), the method of Gifford and Malawista 
3 

(Wehinger) and a quantitative determination of NBT reduction 
8 
developed by Baehner and Nathan (Humbert). The elevated NBT 
83 
responses are said to return to normal levels in 7 - 20 days 
25 82 
or within two months. Park, Holmes and Good have demonstrated 
an increased oxygen consumption, an increased hexose monophosphate 
shunt activity and an increased quantitative NBT reduction in 
the resting state of newborn infants and they interpret the 
"false" positive NBT values as a result of increased metabolic 
activity in the leukocyte. 
Elevated NBT values were also found in the neutrophils of 
healthy premature infants, and those with non-bacterial disease 
19,20 
by Cocchi et.al. who, in addition, found a decrease in NBT 
reduction to "normal" levels (less than 10%) in premature infants 
with bacterial infection. 
E) Miscellaneous - False-positive NBT reduction reactions 
39 
have also been reported in Chediak-Higashi disease, after typhoid- 
39 
paratyphoid vaccine, in a case of suspected drug overdosage without 
67 25 77 
infection, in Hodgkin's disease with fever, in mvelofibrosis, and 
48 
in four out of six patients with hemophilia by Humbert et.al. 
50 
Humbert et.al. also reported elevated NBT reduction,leukocyte 
respiration, and hexose monophosphate shunt activity in several 
patients with ostenogenesis imperfecta, but these results are 
14 
disputed by Brown et.al. The concentration of heparin used in 
80 




determining the ranges of "normal"and has been reported to 
41 
elevate the level of spontaneous NBT reduction by neutrophils. 
The critical role of heparin concentration has also been noted 
in several of my experiments. 
NBT False Negative Reactions 
27 
A) Bacterial Infections - Esposito and Lalla reported 
twelve cases of bacterial meningitis in which the peripheral 
blood neutrophils showed an NBT reduction response within the 
normal range although the neutrophils within the cerebrospinal 
fluid (CSF) showed a strongly positive NBT response. This is 
in contrast to positive NBT reduction findings in peripheral 
80 
blood neutrophils in bacterial meningitis reported by Park ejt.al., 
29,30 67,69 48 
Feigin et.al,, Matula and Paterson, and Humbert et.al. 
77 
Ng reported three out of seven patients with subacute 
bacterial endocarditis (SBE) had NBT reduction values by 
neutrophils within the normal range in contrast to high NBT 
84 
reduction values reported by Park et.al. 
Localized infections can also occasionally give negative 
NBT responses as is the case with four patients reported by 
69 
Matula and Paterson with: staph>jLococcal osteomyelitis (presumably 
after the hematogenous phase); cellulitis due to Group A beta- 
hernolytic streptococci; urethritis-cystitis due to E. coli; 
and an enterococcal pelvic absess. 
Miscellaneous bacterial infections in which the NBT 
5 

response has been negative included a patient with nephrosis 
78 
and pneumococcal peritonitis cited by Park and three cases of 
48 
infected ventriculo-peritoneal shunts reported by Humbert et.al. 
97 ~~ 
B) Drugs - Strauss et.al. found that phenylbutazone 
inhibited both the engulfment and intracellular killing of E_^ 
coli by guinea pig polymorphonuclear leukocytes and also de¬ 
creased the quantitative reduction of NBT by neutrophils 
57 
stimulated with latex particles while Klebanoff and White 
found that methimatazole inhibited the killing of Lactobacillus 
acidophilus by the leukocytes of a patient with chronic granu¬ 
lomatous disease and the patient's mother's, but not by normal 
leukocytes. 
The effect of steroids on the NBT test is controversial. 
73 
Miller and Kaplan report that the quantitative NBT dye reduction 
was decreased in twenty-one children receiving prednisone in a 
dose of 1.0-2.0 mg/kg. compared to normal controls. Matula and 
68 
Paterson report one adult patient on 1 gram of methylprednisolone 
and 150-200 mg. azathioprine daily with peritonitis and multiple 
pelvic absesses in which the spontaneous NBT dye reduction by 
neutrophils was negative, but the "stimulated" NBT test using 
81 
200 ug/ml of bacterial endotoxin described by Park and Good 
77 
was positive. Ng reported low NBT reduction and low "stimulated" 
NBT tests with an undisclosed number of patients on steroids. 
69 
In contract to these results, Matula and Paterson, in another 
paper, describe nine adult patients receiving the equivalent of 
6 

20-120 mg. of prednisone daily in which the NBT test was not 
102 
affected. In addition, a recent paper showed that the NBT 
test was not affected by large doses of steroids and azathioprine 
in renal transplant patients. 
Similar controversy surrounds the effects of immunosuppressive 
73 
or cytotoxic drugs. Miller and Kaplan report normal NBT dye 
reduction in leukemic children receiving 6-mercaptopurine and 
48 
amethopterin, while Humbert et.al report decreased NBT dye 
reauction in two patients with septicemia on cytotoxic drugs 
(histiocytosis X treated with vinblastine and lymphoma treated 
62,63,64 
with nitrogen mustard). Malawista demonstrated that 
vinblastine does inhibit the increased oxygen consumption and 
14 
glucose -1- C oxidation that normally accompanies phagocytosis 
and that it appears to limit lysosomal degranulation even though 
the ingestion process itself and intracellular killing of bacteria 
did not appear to be impaired, although a bacterial killing de- 
65 
feet was postulated in an earlier paper. 
Sulfonamides and certain other anti-inflammatory drugs 
found to be mydoperoxidase (an enzyme important in leukocyte 
bactericidal activity) inhibitors may also result in a false 
61 
negative NBT test but apparently no patients have been tested 
as yet. 
C) Neutrophil metabolic defects/ inherited or acquired - 
The major area where false negative NBT dye reduction 
tests occur is with neutrophil metabolic defects or with some 
impairment in host humoral or cellular defense mechanisms. 
7 

1) Inherited - The classic host defense disease 
with a neutrophil defect in which the NBT dye test is negative 
5,8,75,83. 
is chronic granulomatous disease of childhood. The 
importance of this disease in the development of the NBT test 
and in the elucidation of the mechanism of phagocytosis and intra¬ 
cellular killing of bacteria will be discussed in the next 
61 
section. One patient with hereditary myeLoperoxidase deficiency 
and a patient with complete deficiency of glucose-6-phosphate 
22 
dehydrogenase demonstrated defective bactericidal capacity and 
78,84 
a failure to reduce NBT. In addition, congenital agammaglobulinemia 
has been reported to give negative results. A patient with 
sickle cell disease and Salmonella osteomyelitis has been 
78 
reported to have a false negative NBT dye reduction test, 
presumably due to defective polymorphonuclear leukocvte function 
78 
in this disease. 
2) Acquired - Impaired neutrophil bactericidal capacity 
was demonstrated with five test organisms and a decreased quan¬ 
titative NBT dye reduction test in a 75 year old patient with 
24 
mixed cryoglobulinemia by Douglas et.al, an acquired and 
apparently transient, reversible condition. Certain of the 
48 
false negative NBT reduction group reported by Humbert et.al. 
were postulated to have altered WBC function that may have 
affected the results: two alcoholics, one with Pseudomonas 
aeruginosa brain absesses and one with Streptococcus pyogenes 
8 

subdural empyema; a patient with severe burns and Pseudomonas 
and Candida albicans septicemia; and one case of pneumonia 
12 
complicating an influenza syndrome. Bravton _et ._al. have shown 
that alcohol depresses the rate of leukocyte mobilization 
into traumatized skin of nutritionally normal people but human 
polymorphonuclear leukocytes obtained after alcohol was given 
or leukocytes exposed to alcohol in vitro showed no decrease 
in ability to ingest or kill bacteria. This observation plus 
the fact that no NBT dye reduction tests have been performed in 
leukocytes exposed to alcohol must lead one to doubt alcohol as 
a cause of the two false negative results in infected alcoholics. 
1 
Thermal Burns have been shown to affect neutrophil function 
(phagocytosis and intracellular killing) and influenza virus 
has been shown to reduce the phagocytosis of pneumococci by 
exudate polymorphonuclear leukocytes, macrophaaes, and alveolar 
93 
macrophages in experimental animals. Both could plausibly 
affect WBC function and thus account for false negative NBT 
results. 
Chronic Granulomatous Disease, Phagocytosis, and Intracellular 
Bactericidal Capacity 
11 
In 1957 Berendes, Bridges, and Good characterized the 
features of a new syndrome, also elaborated by Landing and 
59 
Shirkey, which they later named fatal (chronic) granulomatous 
13 
disease of childhood. The syndrome consisted of lymphadenitis, 
9 

hepato-splenomegaly, and pulmonary infiltrates, pathologically 
distinguished by granulomas which were clearly different from 
other infectious and non-infectious granulomatous processes. 
Patients reported with this syndrome have usually been males 
with the onset of severe bacterial disease early in life. 
Polymorphonuclear (PMN) leukocytes of patients with chronic 
granulomatous disease of childhood (CGD) were noted to 
phagocytize bacteria normally but to permit intracellular 
survival of certain bacteria, along with a failure to reduce 
45,75,89 
NBT dye. These basic findings in PMN leukocytes of patients 
with CGD stimulated work which elaborated not only the basic 
features of this rare disease, but also some of the basic meta¬ 
bolic events associated with phagocytosis and intracellular 
reduction and its intimate tie-in with these events. 
The mechanisms of bacterial killing by polymorphonuclear 
leukocytes are not completely understood. Phagocytosis of 
bacteria is associated with the rupture of leukocyte granules 
(lysosomes) and the discharge of their contents into the phago- 
42,57 
cytic vacuole containing the ingested organisms. Leukocytic 
granules contain a variety of antibacterial agents among which 
21,57 21 
are lysozyme, a number of crranular cationic proteins and 
94 
myioperoxidase. There is also a burst of leukocyte metabolic 
activity after phagocytosis that results in a sharp fall in 
57,91 




of hydrogen peroxide by the cell. Normally, these events 
89 
are accompanied by the death of most organisms. Quie et.al 
demonstrated that the total lysozyme and phagocytin activity of 
leukocyte extracts from patients with CGD were similar to control 
leukocytes and they postulated that the deficiency of bactericidal 
capacity of these leukocytes was due to the minimal degranulation 
of lysosomes which they noted after phagocytosis. Further 
43 
studies demonstrated that PMN leukocytes of patients with CGD 
responded to the phagocytosis of latex particles with normal 
increments in glucose consumption, lactate production, Krebs cycle 
activity, and lipid activity as do PMN leukocytes from normal 
54,55 
patients. These events were postulated to be associated with 
43 
the phagocytic process, a logical deduction since phagocytosis 
is normal in both CGD and control leukocytes. However, unlike 
52,54,55,85 
normal leukocytes, the leukocytes of these patients 
fail to show normal increments in respiration, direct oxidation 
of glucose through the hexose monophosphate (HMP) shunt, 
and hydrogen peroxide formation during particle uptake, events 
thought to be associated with lysosomal degranulation and in- 
43 
tracellular bactericidal capacity. In normal leukocytes, 
glycolytic inhibitors such as iodoacetate and fluoride inhibit 
phagocytosis whereas respiratory inhibitors such as cyanide and 
actinomycin A do not, indicating that the energy required for 
97 
engulfment comes from glycolysis. In addition, methylene blue 
equally stimulated HMP activity in control and CGD leukocytes. 
11 

Therefore, the HMP pathway is present in CGD leukocytes, but 
6 
is not stimulated by phagocytosis. 
A unified concept relating the various metabolic abnor¬ 
malities found in CGD has centered around the deficiency of 
H2O2 in the leukocytes of these patients. Leukocytes of patients 
with CGD can kill organisms which produce their own H90 2SUCH 
53 
as streptococci, (catalase negative) but they cannot kill organ¬ 
isms which produce catalase to destroy HO like Staphylococcus 
57 60 22 
or Serratia. Lehrer has demonstrated improved candidacidal 
activity in CGD leukocytes with the use of the H2O2 producing 
90 
drug, phenazine. In addition, Reed has implicated H in the 
stimulation of the HMP shunt and thus in CGD the deficiency of 
H2O2 might also be responsible for the lack of stimulation of 
58 72 
HMP shunt. Klebanoff and McRipley and Sbarra demonstrated 
the bactericidal potential of myeloperoxidase, iodine and H2O2 
in the presence of bact.eria, thus demonstrating a major pathway 
in which H?0? is used to kill bacteria intracellularly. 
48 
Klebanoff and White demonstrated that neutrophils from a patient 
with CGD, unlike normal neutrophils, did not fix iodine after 
the ingestion of heat killed Lactobacillus acidophilus or heat 
killed or live Serratia marcescens♦ When live Lj_ acidophilus 
was employed (produces H2O2), iodination did occur, although 
it was less than normal. 
6-8 4 
Baehner and Nathan and Baehner and Karnovsky have found 
a deficiency of a cyanide-insensitive NADH oxidase in the leukocytes 
12 

of patients with CGD, a finding they believe can account for 
the metabolic abnormalities in their leukocytes. The postulated 
90 
mechanism is as follows: 
2 NADH + 2H+ + 20^ --^2^-2xid§se-2 nad+ + 2 H2O2 
2 H202 + 4 GSH _-.glutathione-2 GSSG + 4 H20 
(reduced peroxidase (oxidized 
glutathione) glutathione) 
2 GSSG + 2 NADPH + 2H+ —glutathione  2 NADP+ + 4 GSH 
reductase 
A deficiency of NADH oxidase would thus account for a lack of 
H202 and indirectly, since NADP+ is a factor known to control 
HMP pathway activity, account for the lack of stimulation of 
HMP shunt activity in the leukocytes of these patients. This 
16 
finding is supported by Cagan and Karnovsky who demonstrated 
that the respiratory burst during phagocytosis in guinea pig 
polymorphonuclear (PMN) leukocytes results from the action of 
a cyanide-insensitive NADH oxidase, which produces H O 
2 2 • 
Further substantiation of this postulate was provided by Baehner, 
5 
Nathan, and Karnovsky who inserted an H2O2 generating system 
into CGD leukocytes by allowing the cells to phagocytize latex 
spherules coated with glucose oxidase. This produced amelioration 
in the known metabolic deficiencies of these cells during 
phagocytosis: a) formate oxidation dependent of H202 production 
increased four times b) HMP shunt activity was markedly 
stimulated and c) there was an increase towards normal levels 
13 

of NBT dye reduction of CGD leukocytes. However, these results 
43 
are contradicted by Holmes, Page and Good, who found that the 
NADH oxidase activity of CGD leukocytes was equal to that of 
normal control leukocytes. 
Previously, I had mentioned that CGD is thought to be 
primarily a sex-lined recessive found most often in males. 
100 
Evidence for this is provided by Windhorst, Holmes and Good 
who found two populations of cells in PMN leukocytes of carrier 
females. Leukocytes of all eight mothers and several sisters 
of affected male patients were intermediate in bactericidal 
capacity and quantitative NBT dye reduction between leukocytes 
of affected boys and controls in line with the Lyon hypothesis. 
8,57,75 
This result has been verified by others. However, a few 
8,88 
cases of CGD have been reported in female children in which 
no clinical or laboratory evidence of a leukocyte abnormality 
(including normal NBT dye reduction) could be demonstrated in 
family members, prompting an hypothesis that these cases could 
be instances of autosomal recessive inheritance. Interestingly, 
44 
Holmes et.al. found that leukocyte glutathione peroxidase 
activity was significantly diminished in two female patients 
with CGD as compared to control leukocytes. By contrast, 
leukocytes of male patients with CGD showed normal activity of 
4 4 
this enzyme. To support their position, Holmes ejt.al. have 
cited the following postulated reactions to account for the 
metabdic deficiencies of CGd leukocytes in their female patients 
96 





GSSG + NADPH + H+ - 
glucose-6-PO, + 2 NADP+ -^ME- 
H pathway 
+ NADPH oxidase 
NADPH + H + 0n - 
/L 
glutathione 
H202 + 2 GSH -pefoxiaaii- 
- 2 GSH + NADP + 
2 NADPH + 2H+ + C02 
- NADP+ + H202 
GSSG + H20 
In their scheme, a limitation in the pathway due to a deficiency 
of glutathione peroxidase would block the cycle by limiting the 
availability of GSSG (oxidized glutathione), the substrate for 
glutathione reductase. Normal stimulation of the HMP pathway 
would not occur, and oxygen consumption and hydrogen peroxide 
production would be blocked owing to a lack of NADPH. 
Thus two enzyme defects are postulated in CGD; an NADH 
oxidase defect reported in both male and female CGD patients 
and a glutathione peroxidase defect reported in certain female 
but not male patients with CGD, each presented with theoretical 
reactions which could account for the lack of H^O^ production 
and the lack of stimulation of HMP shunt activity in the leukocytes 
of these patients thus accounting for the bactericidal defect 
and possibly for the mechanism of NBT reduction. 
Theories on the Mechanism of NBT Dye Reduction 
The major theory concerning the mechanism of increased 
78 
NBT dye reduction during bacterial infection assumes: 1) that 
the phagocytosis system of the host, both cellular and humoral, 
is operating normally and 2) that the infection involves the 
15 

This idea of the NBT test is based on systemic circulation. 
80 
the hypothesis that a metabolic change and an increased reduction 
of NBT dye would take place when leukocytes are involved in vivo 
during a natural infection. Oxidized (yellow) NBT dye in solu¬ 
tion does not penetrate cell membranes well, since it is positively 
86 
charged, therefore it is presumed that the NBT has to enter 
the cell attached to a phagocytized particle or in the fluid 
75 
around it. The theory is that NBT dye reduction is increased 
in bacterial infection as opposed to normal controls or nonin- 
fectious fevers because contact with bacteria or bacterial 
25,27 
products stimulates phagocytosis and thus ingestion of the dye. 
The increased intracellular metabolism within the polymorphonuclear 
leukocyte, which is stimulated by phagocytosis, presumably is 
also associated with the increased reduction of the oxidized, 
78,80,81 
yellow NBT dye to a reduced, blue-black formazan precipitate. 
8 
Baehner and Nathan, from their studies of CGD leukocytes, feel 
that NADH oxidase is the intracellular enzyme responsible for 
NBT dye reduction in the PMN leukocyte. The importance of 
phagocytosis can be illustrated by the method of Gifford and 
37 
Malawista. Isolating granulocytes by allowing them to adhere 
to a glass surface, these investigators found a high NBT re¬ 
duction in normal granulocytes. In the presence of infection 
the percentage of NBT (+) cells did not increase, presumably 
since the granulocytes were already "phagocytizing" glass and 
thus maximally stimulated. 
16 

There is also experimental support that contact with 
bacteria or bacterial products is responsible for the increased 
20 
NBT dye reduction during bacterial infection. Cocchi demonstrated 
increased NBT dye reduction when polys were incubated with 
81 69 
Pseudomonas. Park and Good and Matula and Paterson also 
showed stimulation of NBT dye reduction when the PMN leukocytes 
were incubated with endotoxin. Staphylococcal protein-A and 
streptolysin-0 can also induce an increased reduction of NBT 
78 
dye when they are added to whole blood, thus it is assumed that 
any bacterial product or bacterial component may also be 
responsible for the increased NBT dye reduction with bacterial 
infection by stimulating increased phagocytosis and intracellular 
reduction of the dye. 
39 
Crush feels that contact with bacteria or particulate 
matter to stimulate the PMN leukocytes does not have to be 
postulated and that lysosomal instability presumably can just 
be the cause of increased NBT reduction. 
38 
Gifford and Malawista, in examining NBT dye reduction by 
their method under different experimental conditions, concluded 
that the permeability of the granulocyte to NBT may be the 
critical variant and can be altered by changes in NBT concen¬ 
tration, particle ingestion, and adherence to a surface. 
They postulated that reports which describe an increase or 
decrease in NBT reduction associated with certain clinical dis¬ 
orders need not be interpreted to represent a stimulation or 
17 

depression of the enzyme system(s) necessary for NBT reduction 
(or bactericidal capacity) as in CGD, but may be due, at least 
in part, to change in cell permeability to NBT. 
Cystic Fibrosis 
Cystic Fibrosis is a hereditary disease of children, 
adolescents, and young adults in which there is a generalized 
dysfunction of exocrine glands. The triad of chronic pulmonary 
disease, pancreatic insufficiency and abnormally high sweat 
15,16,23 
electrolytes is present in most patients. Hepatic 
cirrhosis, intestinal obstruction edema, malabsorption, nasal 
polyps, rectal prolapse and many other manifestations may be 
part of the clinical picture of this protean disease. Most 
of these symptoms are thought to be secondary to obstruction 
of the organ passages (such as bronchioles, pancreatic ducts 
23 
and biliary ductules). There is general agreement that C.F. 
is due to an inborn error of metabolism transmitted as an auto¬ 
somal recessive trait with an incidence of about 1 in 2000 
live births in countries with populations predominantly of 
76 
Caucasian descent. The etiology of the disease is unknown, 
but many studies have focused on the abnormally viscid mucus 
as the key to understanding this disease. It has been suggested 
34,35 
by Gibson, Matthews and Minihan that a primary biological 
function of mucus is to protect cell membranes from hydrostatic, 
osmotic, and concentration gradients. The consequences predicted 
18 

for an impairment of this function (which would make mucus 
"leaky" or "hyperpermeable") fit in with most of the known 
characteristics of exocrine secretions from patients with 
cystic fibrosis. Cystic fibrosis (C.F.) mucus was shown to 
be hyperpermeable in vitro and serum from patients with C.F. 
can induce hyperpermeability in vivo. Apart from its viscosity, 
the most definitive abnormality of C.F. mucus is the quantitative, 
but not qualitative difference between the electrophoretic 
patterns produced by C.F. and normal submaxillary glycoprotein. 
This difference seems entirely due to calcium since the addition 
of calcium to normal mucus produces a C.F. pattern, while the 
removal of calcium from C.F. mucus with editic acid produces a 
40 
normal pattern. This is especially interesting since probably 
all C.F. exocrine secretions contain excess calcium. In the 
34,35 
studies by Gibson, Matthews, and Minihan, calcium was found 
to increase mucus permeability in vitro and in. vivo and, when 
iontophoresed into the skin, to raise the salt concentration 
of sweat. They postulated that C.F. patients may have normal 
mucus, but secrete an excess amount of calcium which combines 
with the mucus and renders it hyperpermeable. 
Application of the NBT Dye Test to Cystic Fibrosis: 
Experimental Proposals 
As was mentioned previously, C.F. patients are prone to 
numerous pulmonary infections and it is usually respiratory 
insufficiency secondary to chronic pulmonary disease that is the 
19 

cause of their demise. Infection developing distal to mucus 
plugs in bronchioles is the most likely explanation for their 
frequent infections, but a defect in these patients' poly¬ 
morphonuclear leukocytes has not yet been ruled out. It is 
difficult to assess the presence or absence of acute bacterial 
infection in these patients since pathogens are frequently 
grown from the sputum of even asymptomatic patients and other 
clinical parameters may be non-contributory. In addition, even 
if antibiotic therapy is started for a presumed flareup of 
lung disease, its effectiveness is difficult to assess since 
often appropriate antibiotics may not change the patient's 
36 
sputum flora. 
Since the recently introduced NBT dye reduction test has 
been shown to be a useful guide in the diagnosis and management 
29,30,48,69,80 
cf bacterial infections, I decided to use the NBT 
test in order to determine: 
1) whether there was any difference in NBT dye reduction 
by leukocytes of C.F. patients as compared to normal controls 
as one method of determining the presence or absence of a 
bactericidal defect in polymorphonuclear leukocytes of C.F. 
patients. 
2) whether the NBT test could be used as a useful parameter 
in determining the presence or absence of an acute bacterial 
infection in these patients. 
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3) whether the NBT test would be a useful guide to assess 
the effectiveness of antibiotic therapy in these patients. 
Other clinical parameters such as white blood cell count, 
band shift, temperature, physical findings, sputum cultures 
and chest X-ray results were also examined to determine their 




Methods and Materials 
Patients 
157 nitroblue tetrazolium (NBT) dye tests were performed 
on heparinized venous blood obtained from 78 cystic fibrosis 
(C.F.) patients seen at Yale-New Haven Hospital during the 
period December 1971-May 1972. The diagnosis of cystic fibrosis 
was established in these patients by means of elevated sweat 
33 95 
chloride determinations and a typical clinical picture. The 
patients ranged in age from 7 months to 26 1/2 years with a 
mean of 8.6 years. 
At each visit, the patients were placed into one of five 
95 
groups on the basis of the Shwachman Chest X-ray score (see 
Table 8) and the clinical assessment of the senior physician 
on the basis of history, physical examination, chest x-ray, 
and other laboratory parameters if available. The results of 
the NBT dye test were not known at the time the categorization 
was made and the clinical assessment was not known to the person 
reading the results of the NBT test. 
The groupings were as follows: Group I patients had 
Shwachman Chest X-ray scores greater than 19 and were stable 
and doing well. Group II patients also had Shwachman Chest X-ray 
scores greater than 19 but were thought to have an acute flareup 
of their disease with an increase in respiratory symptomatology 
and a pulmonic process thought to be bacterial. Group III 
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patients had more chronic changes in their lungs with Shwachman 
Chest X-ray scores less than 19 but were thought to be stable 
and doing well, on or off antibiotics. Group IV patients 
had Shwachman Chest X-ray scores less than 19 but were thought 
to have an acute flareup of their disease with an increase in 
respiratory symptomatology and a pulmonic process thought to be 
bacterial. Group V patients were a small, difficult group to 
clinically define with Shwachman Chest X-ray scores less than 
19 who were thought to be chronically infected and gang gradually 
downhill without ever going back to a stable baseline - con¬ 
tinuously doing poorly with exercize intolerance, dyspnea or 
tachypnea, bouts of hemoptysis, copious sputum production, poor 
A 
pulmonary function tests, with rales and rhonchi consistently 
heard in their chest and on continuous antibiotic therapy 
without amelioration of symptoms. 
I also analyzed my results by dividing the patients into 
those judged clinically well (Groups I and III) , those judged 
clinically sick (Groups II and IV) and those judged to be 
chronically infected (Group V). 
I also compared the results of the NBT test with other 
clinical parameters - white blood cell count, band shift (shift 
to the left in the polymorphonuclear (PMN) leukocyte series), 
A 
temperature, the presence or absence of rales, sputum culture 
results and findings on chest x-ray to see how good an indicator 
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each might be in predicting the presence or absence of a 
bacterial infection. 
Laboratory Methods 
The NBT dye test was performed according to the method 
80 
of Park et.al with a slight modification. One cc of venous 
blood was drawn into a plastic syringe and transferred to a 
disposable plastic tube to which 100 units of heparin were added. 
At the same time, blood was drawn for a white blood cell count 
and differential count to be performed by the Yale-New Haven 
Hospital Hematology Lab, or, in certain instances, by myself. 
Approximately 0.1 ml. of this heparinized blood was then trans¬ 
ferred into a clean, concave microslid.e (Macalaster-Bicknell 
Co., New Haven, Conn.) and mixed with an equal amount of NBT 
solution (a mixture of equal amounts of 0.2% NBT (Nutritional 
Biochemicals Corp., Cleveland) in physiological saline solution 
and 0.15 M phosphate-buffered saline solution - pH 7.2). The 
slides were placed in petri dishes containing wet gauze to 
provide humidity and were then incubated at 37°C. for 15 minutes 
and subsequently kept at room temperature for an additional 15 
minutes. At the end of this period, the blood-NBT mixture was 
again mixed using a small wooden applicator stick. Coverslip 
smears were carefully made, air dried, and counterstained with 
Wright's stain. The tests were all performed within 1/2 hour 




Wright stained smears were examined under the microscope 
with the high, dry objective (450X). Initially three separate 
counts of 100 neutrophils each was performed on each test but 
since a good correlation was obtained on each of the counts, 
only 100 neutrophils were counted for the majority of tests. 
Monocytes were not counted. Only those cells which were intact 
and could be clearly identified as neutrophils with a discrete 
deposit of blue-black formazan were classified at NET positive. 
The intracellular formazan deposit could be either in the form 
of a "clump" or a "streak" of blue-black granules. The absolute 
number of positive neutrophils per cu. mm. was calculated 
using the white blood cell count, differential, and the percentage 
of NET (+) neutrophils. In our study, as well as 
scores above 10% were considered abnormal, or NBT 
correlating with the presence of active bacterial 
NBT scores below 10% were considered to be in the 
but were also seen in patients with viral disease 










131 tests on 78 separate patients with cystic fibrosis 
were classified into one of five groups according to the criteria 
discussed earlier. Twenty-six tests were not classified into 
one of the five groups because they were part of sequential 
studies taken while the patients were on antibiotics for a 
presumed flareup of respiratory infection and will be discussed 
separately. 
Table 1 shows the results of the one hundred thirty-one 
tests broken down according to the five groups. The results 
are also analyzed as to the number of tests in each group that 
had less than or equal to 10% of the neutrophils reducing the 
dye and those that had greater than 10% of the neutrophils 
reducing the dye. The results of my scatter plot of values 
(Figure 2) indicated that 10% NBT ( + ) neutrophils would be a 
good cutoff point in my series. Patients placed in Group I 
had an age range from 2-19 1/2 years and had a mean percentage 
of NBT ( + ) neutrophils of 7.4 + 5.1% with a range of 1-32%. 
Thirty-eight tests had an NBT score less than or equal to 10% 
and four had an NBT score greater than 10% which is statistically 
significant (p^.QOl). Of the four patients with NBT scores 
^10%, two values (11% and 32%) were obtained on two separate 
occasions from one patient thought to be clinically healthy; 
another value of 11% on a clinically healthy patient and a 
value of 20% on a patient thought to be stable at the time 
of his clinic visit but who spiked a temperature to 102°F. 
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that night with increased cough and sputum production. 
Patients placed in Group II with a presumed flareup of 
respiratory infection had an age range from 7 months to 18 
years and had a mean percentage of NET (+) neutrophils of 
23.1 + 11.3% with a range of 9-56%. Eighteen tests had an 
NBT score of greater than 10% and one test (9%) had an NBT 
score less than or equal to 10%, which is statistically 
significant (p<.001). 
Patients placed into Group III had an age range from 
1-18 years with a mean percentage of NBT (+) neutrophils of 
6.3 +2.5% with a range of 2-14%. Forty tests had an NBT 
score of <10% and two tests (11% and 14% on two separate 
patients) had an NBT score of greater than 10% which is 
statistically significant (p<.0Ql). 
Group IV patients with a presumed flareup of respiratory 
infection had an age range from 3-26 1/2 years with a mean 
percentage of NBT ( + ) neutrophils of 17.4 + 5.6% with a range 
of 4-27%. Nineteen tests had an NBT score of greater than 10% 
and two tests (8% and 4% on two separate patients) had an NBT 
score of ~bl0%, which is statistically significant (p<.001). 
Group V contained a small number of patients wth an 
age range from 5-19 1/2 years with a mean percentage of NBT (+) 
neutrophils of 9.4 + 3.4% with a range of 5-15%. Five tests 
had an NBT score of <10% and two tests had an NBT score greater 
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than 10%, which was not significant. 
Table 2 analyzes the results of the NBT percentage 
breakdown according to whether the patient was thought to be 
clinically infected (Groups II and IV), clinically stable 
(Groups I and III), or chronically infected (Group V). In 
those patients thought to be clinically stable (84 tests on 
62 patients) , seventy-eight tests (93%) had an NBT score of 
10% and six tests (7%) had an NBT score greater than 10%, 
which is statistically significant (p.<1.001). In those 
patients thought to be clinically infected (40 tests on 34 
patients), thirty-seven tests (93%) had an NBT score of greater 
than 10% and three (7%) had an NBT score of £-10%, which is 
statistically significant (p<.0Ql). Five tests in those 
patients thought to be chronically infected had an NBT score 
of £10% and two tests had an NBT score of greater than 10%, 
whichis not statistically significant. 
Table 3 shows the results of the mean percentage of NBT (+) 
neutrophils, the mean absolute number of NBT (+) neutrophils, 
the mean white cell count, the mean percent band forms, the mean 
temperature and the change in sputum flora in those patients 
thought to be clinically stable (Groups I and III) and those 
thought to be clinically infected (Groups II and IV). These 
same parameters were also analyzed in Table 4 according to the 




based on 84 tests on 62 clinically stable patients was 6.8 +4.0% 
while the mean NBT % in 40 tests on 34 clinically infected 
patients was 20.1 + 9.1%, which is a statistically significant 
difference (p<.01). The mean absolute number of NBT (+) 
neutrophils is also statistically significant (p^.001) between 
the two groups, the mean of those clinically stable being 
448.2 + 330.8 and the mean of those thought to be clinically 
infected of 1412.9 + 1263.8. The mean white blood cell count 
(11,500 + 3,400 vs. 11,500 + 4400), band shift (2.5 + 3.6 vs. 
4.9 + 6.7) and temperature (98.8oFe + 0.8 vs. 99.8oF* + 1.5) 
were not statistically significant between the clinically 
infected and clinically not infected groups. 
Other clinical parameters were analyzed in these patients. 
Table 5 shows the results of sputum cultures taken on these 
patients broken down into the type of organism isolated for 
each of the five groups and whether there was any change in the 
organism(s) isolated from the most recent culture. Only Group I 
has a significant number of sputum cultures with normal flora 
(21 out of 42) while Pseudomonas appears to be the most commonly 
isolated organism, increasing in proportion as we go from 
Group I to Group V. Staphylococci and coliform organisms are 
less frequently isolated and Hemophilus influenza is rarely 
isolated in our clinic. There was not much difference between 
the first four groups in the proportion of cultures in which 
there was a change in the organism(s) isolated from the previous 
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culture: 20/42 in Group I; 8/19 in Group II; 17/42 in Group III 
and 9/21 in Group IV. In Group V only one out of seven cultures 
showed a change in the organism(s) isolated. 
Table 6 depicts the presence or absence of a change in 
the chest x-ray in each of the five groups. In most instances, 
chest x-rays were not done on that particular day, but in the 
few that were, a new infiltrate was found in 4 out of 5 films 
taken in Group II patients but in only 3 out of 9 of the patients 
in Group IV. In the clinically stable groups, Group I had no 
films with a new infiltrate and Group III had a change in 4 out 
of 15 films. In Table 7 rales were found to be present in 9 
and absent in 56 of those patients thought to be clinically 
stable and to be present in 18 and absent in 12 thought to be 
clinically sick. 
Sequential Studies 
Fourteen patients have been serially followed with NBT 
examinations during 16 bouts of presumed bacterial pneumonitis. 
Prior to their flareup in respiratory symptoms, each patient 
had a "normal" value of £10%NBT (+) neutrophils. With the onset 
of the presumed acute bacterial pneumonia, the percentage of 
NBT (+) neutrophils rose into the "infected" range of greater 
than 10% in all the patients studied. 
In 11 instances of presumed bacterial infection, the 
institution of antibiotic therapy "appropriate" for the patient's 
30 

sputum flora was followed by a prompt resolution in clinical 
symptomatology and a return of the NBT to "normal" levels. 
In two instances the NBT test remained elevated and the patients 
remained symptomatic until an empiric change in antibiotics was 
instituted, whereupon clinical improvement coincided with a 
decrease in NBT test to "normal" levels. In three patients, 
the NBT test did not return to normal and the clinical condition 
deteriorated in these cases. Figure 1 illustrates the response 
of the NBT test to antibiotic therapy in two patients, one of 
whom (pt. B) had a prompt clinical response and a return of 
the NBT to "normal" levels and one patient (pt. A) just 
previously mentioned who failed to show a clinical response to 





Seventy-eight patients with cystic fibrosis of the 
pancreas were studied prospectively for six months to see if 
the NBT test would be of value in evaluating these children. 
The results of the NBT test in these patients provide useful 
answers to the three experimental proposals previously elaborated: 
1) The results of the NBT dye test indicate that the 
leukocytes of patients with cystic fibrosis reduce the dye in 
the same relative proportions as do the leukocytes of normal 
control patients with or without bacterial infection. The 
mean percentage of neutrophils reducing the NBT dye in our 
patients with cystic fibrosis who were clinically stable 
(Groups I & III) was 6.8 + 4.0%, which is in no way different 
from normal, healthy controls without cystic fibrosis either 
29,30,48,69,80 
in our laboratory (5.1 + 3.6%), or as reported by others. 
The positive NBT tests (mean 20.1 + 9.1%) in our patients with 
cystic fibrosis with suspected bacterial infection of the 
respiratory tract was similar to control patients with 
bacterial infection both in our lab (20.0 + 6.9%) and as 
2,29,30,48,67,69,80 
reported by others. 
2) The results indicate that the NBT test is a very 
useful parameter in determining the presence or absence of 
suspected acute bacterial infection in these patients. An 
NBT test result with <10% of the patient's neutrophils reducing 
the dye was correlated in 78 out of 84 instances with a patient 
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thought to be clinically stable (Groups I & III) while an NBT 
test result of^>10% of the patient's neutrophils reducing the 
dye was correlated in 37 out of 40 instances with the diagnosis 
of probable acute bacterial respiratory infection (Groups II & 
IV). It is significant in looking at our six false positive 
results that one (20%) was in a patient thought to be clinically 
stable at his clinic visit in the afternoon, but who developed 
a temperature of 102°F. with increased cough and sputum production 
that night and that our highest false positive value by far (32%) 
was in a girl who had elevated values (11% and 32%) on two 
separate occasions without any evidence of acute bacterial 
disease. The results of the NBT test in our group of chronically 
infected patients (Group V) shows a random distribution around 
the 10% cutoff point. This result is not too surprising when 
one considers that these patients are more or less continuously 
infected and are probably intermittently having acute invasion 
of bacteria across bronchial walls. Alternate explanations 
include possible metabolic deficiencies in their leukocytes 
induced by long-standing disease or by prolonged antibiotic 
therapy. The NBT test appears to be particularly helpful in 
patients with chest x-ray scores under 19 (Groups III, IV, V) 
since this group of patients frequently have Pseudomonas as 
the predominant flora (see Table 5), and evidence of an acute 
infection requires replacement of an oral antibiotic with 

parental antibiotics such as Gentamicin, Colymicin, or 
46 
Carbenicillin. 
3) Results on a limited number of patients (16 instances 
of probable bacterial infection in 14 patients) indicate that 
the NBT test appears to be a useful guide in assessing the 
effectiveness of antibiotic therapy in patients with cystic 
fibrosis. In each of the 14 patients a normal baseline NBT 
value became elevated into the positive range ( >10%) with the 
onset of a probable acute bacterial infection. In 11 instances, 
the institution of appropriate antibiotic therapy was followed 
by prompt resolution of the clinical signs and symptoms and was 
accompanied by a decrease in the NBT test to normal levels. In 
two instances the NBT test remained elevated and the patients 
remained symptomatic until a change in antibiotic therapy was 
instituted, whereupon clinical improvement and a decrease in 
the NBT results to normal levels occurred. In two instances the 
patients showed a poor response to antibiotic therapy and their 
NBT values remained elevated. One patient died and the other 
was discharged from the hospital with little clinical improvement. 
Another terminal patient with cystic fibrosis was admitted to 
the hospital and put on an antibiotic regimen which resulted 
in the fall in his NBT test to normal levels within three days 
although he expired later that third day. Whether his therapy 
was effective in treating his probable bacterial pneumonia and 
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his death secondary to chronic pulmonary insufficiency with 
hy;oxia and cardiorespiratory arrest or whether this was a 
false negative result is unknown. 
Also significant was my analysis of other clinical 
parameters usually helpful in the diagnosis of bacterial disease. 
The mean white blood cell count, the mean percent band forms, 
the mean temperature and the number of patients with a change 
in sputum flora from previous culture were not significantly 
different between those patients thought to be clinically stable 
(Groups I & III) and those patients (Groups II & IV) thought to 
be clinically infected (Tables 3 & 4). The presence or absence 
of rales (Table 7) was not a consistent help in differentiating 
those thought to be clinically sick from those thought to be 
clinically stable. In a limited number of studies, the presence 
or absence of a new infiltrate on chest x-ray (Table 6) was 
helpful only in differentiating Group I patients (10 out of 10 
showed no change on chest x-ray) from Group II patients (4 out 
of 5 showed a new infiltrate on chest films). The chest x-ray 
did not appear to be useful in differentiating Groups III, IV, 
or V most probably because chronic changes in the lungs of these 
patients tend to obscure the presence of a new infiltrate. 
Sputum culture results (Table 5) indicate that only Group I 
has a significant number of cultures with normal flora (21 out 
of 42) while Pseudomonas appears to be the most commonly 
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isolated organism, increasing in proportion as we go from Group I 
to Group V. That Pseudomonas appears to be the most commonly 
isolated organism in our series, with less isolates of 
Staphylococcus and coliform organisms and very few isolates of 
47,51,56 
Hemophilus influenza is in disagreement with other studies 
in which the Staphylococcus is the most common pathogen isolated 
followed by Pseudomonas, H. influenza and the coliforms. Also 
significant was the fact that there was not much difference 
between the first four groups in the proportion of cultures 
in which there was a change in the organism(s) isolated from 
the previous study. Thus, the classical rule of isolating the 
pathogen and treating with appropriate antibiotics is clouded 
in patients with cystic fibrosis in which acute flareups of 
bacterial infection may not be reflected by changes in their 
sputum flora. In addition, the classical rule of treating 
the infection until the pathogen disappears and clinical 
improvement occurs also does not complete^hold in patients 
with cystic fibrosis in which appropriate antibiotic therapy 
may not change the sputum flora (probably because effective 
concentrations of the antibiotic cannot penetrate into the 
6 6 
sputum). In our patients clinical improvement and the 
return of the NET test to normal after antibiotic therapy was 
frequently not accompanied by a change in sputum flora. 
In my study, the absolute number of NBT (+) neutrophils 
was also statistically significant (p <.001) between those 
patients in Groups I & III thought to be clinically stable 
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(448.2 + 330.8/cu. mm.) and those patients in Groups II & IV 
thought to be clinically infected (1412.9 + 1263.8/cu. mm.) 
(see Table 3). However, in analyzing the scatter plot of 
values (Figure 2) it was decided that a cutoff of 10% NBT (+) 
neutrophils would be both a simpler and more reliable test. 
In addition, a simple analysis of the scatter plot indicates 
that discriminant analysis using the percentage of NBT (+) 
neutrophils and the absolute number of NBT (+) neutrophils 
29,30 
per cu. mm. in the style of Feigin's nomogram would not be 
more beneficial than the simple cutoff of 10% NBT (+) neutrophils. 
One reason to account for the failure of discriminant analysis 
to be beneficial in examining our results is the failure of the 
white blood cell count to increase significantly with infection 
in our patients with cystic fibrosis as compared to most normal 
control patients with infection. 
An important objection to this study is that the significance 
of the NBT test has been assessed by clinical judgment together 
with other available laboratory data. The clinical parameters 
which usually indicate bacterial infection can be misleading 
in patients with cystic fibrosis as discussed earlier. At 
times, the only symptoms of an acute flareup of respiratory 
disease might be an increased cough. It is also frequently 
impossible to know if an increase in symptomatology in these 
patients harboring respiratory pathogens indeed have a bacterial 
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or viral infection as a cause on many occasions. For this 
reason, our patients thought to be clinically infected with a 
probable bacterial infection had this diagnosis made primarily 
on the judgment of the senior clinician in the cystic fibrosis 
clinic. Secondary supporting evidence for the diagnosis was 
made in most cases by the response of the "probable" bacterial 
infections to antibiotic therapy or to a change in antibiotic 
therapy, which resulted in a prompt decrease in respiratory 
symptomatology. There is also abundant evidence, based mainly 
80 29,30 
on studies by Park et.alL, Feigin et.al_ and Matula and 
67,69 
Paterson and from our laboratory that a high NET test 
correlates very well with the presence of bacterial infection 
and there is abundant evidence that patients with cystic 
fibrosis develop recurrent infections in the lower respiratory 
tract. 
I would conclude, based upon the data presented, that 
the NBT test is a valuable parameter, along with a careful 
history, physical examination, and other laboratory data in 




One hundred fifty seven nitroblue tetrazolium (NBT) dye 
tests were performed on seventy-eight patients with cystic 
fibrosis. A "positive" NBT response of > 10% was significantly 
correlated with the presence of presumed bacterial respiratory 
infection and stable patients had "normal" NBT scores below 
10%. Serial determinations in sixteen instances of bacterial 
infection were helpful in evaluating response to therapy. 
Total leukocyte count, mean percentage of immature polymorphonu¬ 
clear leukocytes, temperature or a change in sputum flora were 
not helpful in detecting bacterial infection in these patients. 
The NBT test is a valuable adjunct in the surveillance 
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Correlation of the presence or absence of rales with the 
clinical diagnosis and the Shwachman chest x-ray score. 
Clinically Well 
(Groups I & III) 
Clinically Sick 




Present 9 18 6 
Rale s 
Absent 56 12 4 
Chest x-ray score Chest x-ray score 
>19 <19 
Rales 
Present 7 26 
Rales 
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